Administration of prosultiamine for HTLV-1-associated myelopathy may improve not only voiding symptoms but also storage symptoms by decreasing urinary nerve growth factor levels

Abstract Category

Pharmacology: Clinical

Links
	Abstract 696
	Read By Title Scientific Non Discussion Abstract Session 35
	Pharmacology Voiding Dysfunction Detrusor Hypocontractility Detrusor Overactivity Underactive Bladder
	1. Department of Urology, Nagasaki University School of Medicine, 2. Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University
Abstract PDF Edit Abstract Abstract Centre